ISB News

New Study: Using Single-Cell Technology to Predict Cell Behavior

In a study published in PLOS BIOLOGY, researchers at Institute for Systems Biology (ISB) explain how they developed a new theory for predicting cell-fate decisions and demonstrate, for the first time, that cells indeed undergo a critical transition – or tipping point – when they commit to a particular lineage.

Jan. 9, 2017

3 Bullets:

  • ISB researchers developed a new theory that uses state-of-the-art single-cell technology to make predictions about how cells will behave in the future.
  • The method can predict when a cell will experience a so-called tipping point before it happens.
  • Being able to predict these critical transitions in cells may have life-saving ramifications in the ability to detect early warning signals for disease.

By Dr. Sui Huang

Stem cells hold enormous potential for cell-based therapy in regenerative medicine, if we can use drugs in the lab to push the patient’s own stem cells to become desired cell types, such as blood, liver, or heart cells. So far, our successes in controlling the generation of specific cell types have been empirical. Researchers have painstakingly mapped out many of the genes involved in the cell-fate-decision processes. But we still have little clue about the fundamental principles that govern how a multipotent stem cell, which has the potential to become more than one type of cell, makes a decision to become a specific cell type. We have not had a formal theory for such cell-fate decisions – until now.

In a study published in PLOS BIOLOGY, researchers at Institute for Systems Biology (ISB) explain how they developed a new theory for predicting cell-fate decisions and demonstrate, for the first time, that cells indeed undergo a critical transition – or tipping point – when they commit to a particular lineage. The team designed a new computational approach that utilizes single-cell resolution gene-expression profiling data to compute an index that indicates an imminent tipping point in cells before it happens. READ MORE….

Recent Articles

  • 2024 Year in Review

    Reflecting on the past year, ISB has a lot to celebrate: groundbreaking research published in leading scientific journals, well-earned promotions, widespread media coverage, and more. Enjoy our year-in-review roundup highlighting some of the important, interesting, and impactful highlights of 2024.

  • My Digital Gut

    ISB Named Winner of 2024-2025 Amazon Web Services IMAGINE Grant for Nonprofits

    ISB has been selected as a winner of the 2024 Amazon Web Services (AWS) IMAGINE Grant. The grant will support ISB’s continued development of My Digital Gut, an online decision-support platform that will help make microbiome-informed nutrition and healthcare personalized, predictive, and preventive. 

  • ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever 

    ISB Associate Professor Dr. Wei Wei and his colleagues have developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient.